Aminopyrimidine derivatives as phosphatidylinositol phosphate kinase inhibitors
US12006332B2 · kind B2 · utility
0Cited by
21References
15Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 14, 2022 |
| Grant date | Jun 11, 2024 |
| Priority date | — |
| Expiry date | Jan 14, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D498/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention relates to inhibitors of PI5P4K inhibitors useful in the treatment of cancers, neurodegenerative diseases, inflammatory disorders, and metabolic diseases, having the Formula:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.